147 related articles for article (PubMed ID: 10996419)
1. Prognostic significance of platelet and microvessel counts in operable non-small cell lung cancer.
Cox G; Walker RA; Andi A; Steward WP; O'Byrne KJ
Lung Cancer; 2000 Sep; 29(3):169-77. PubMed ID: 10996419
[TBL] [Abstract][Full Text] [Related]
2. Vascular endothelial growth factor, platelet-derived endothelial cell growth factor and angiogenesis in non-small-cell lung cancer.
O'Byrne KJ; Koukourakis MI; Giatromanolaki A; Cox G; Turley H; Steward WP; Gatter K; Harris AL
Br J Cancer; 2000 Apr; 82(8):1427-32. PubMed ID: 10780522
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of angiogenesis in operable non-small cell lung cancer.
Giatromanolaki A; Koukourakis M; O'Byrne K; Fox S; Whitehouse R; Talbot DC; Harris AL; Gatter KC
J Pathol; 1996 May; 179(1):80-8. PubMed ID: 8691350
[TBL] [Abstract][Full Text] [Related]
4. Angiogenesis as a prognostic indicator of survival in non-small-cell lung carcinoma: a prospective study.
Fontanini G; Lucchi M; Vignati S; Mussi A; Ciardiello F; De Laurentiis M; De Placido S; Basolo F; Angeletti CA; Bevilacqua G
J Natl Cancer Inst; 1997 Jun; 89(12):881-6. PubMed ID: 9196255
[TBL] [Abstract][Full Text] [Related]
5. A biological staging model for operable non-small cell lung cancer.
Cox G; Jones JL; Andi A; Waller DA; O'Byrne KJ
Thorax; 2001 Jul; 56(7):561-6. PubMed ID: 11413356
[TBL] [Abstract][Full Text] [Related]
6. Patterns of angiogenesis in nonsmall-cell lung carcinoma.
Offersen BV; Pfeiffer P; Hamilton-Dutoit S; Overgaard J
Cancer; 2001 Apr; 91(8):1500-9. PubMed ID: 11301398
[TBL] [Abstract][Full Text] [Related]
7. Bcl-2 is an independent prognostic factor and adds to a biological model for predicting outcome in operable non-small cell lung cancer.
Cox G; Louise Jones J; Andi A; Abrams KR; O'Byrne KJ
Lung Cancer; 2001 Dec; 34(3):417-26. PubMed ID: 11714539
[TBL] [Abstract][Full Text] [Related]
8. Vascular endothelial growth factor expression in stage I non-small cell lung cancer correlates with neoangiogenesis and a poor prognosis.
Han H; Silverman JF; Santucci TS; Macherey RS; d'Amato TA; Tung MY; Weyant RJ; Landreneau RJ
Ann Surg Oncol; 2001; 8(1):72-9. PubMed ID: 11206229
[TBL] [Abstract][Full Text] [Related]
9. Tumor angiogenesis in predicting the survival of patients with stage I lung cancer.
Medetoglu B; Gunluoglu MZ; Demir A; Melek H; Buyukpinarbasili N; Fener N; Dincer SI
J Thorac Cardiovasc Surg; 2010 Nov; 140(5):996-1000. PubMed ID: 20708755
[TBL] [Abstract][Full Text] [Related]
10. Microvessel density as a prognostic factor in non-small-cell lung carcinoma: a meta-analysis of individual patient data.
Trivella M; Pezzella F; Pastorino U; Harris AL; Altman DG;
Lancet Oncol; 2007 Jun; 8(6):488-99. PubMed ID: 17513172
[TBL] [Abstract][Full Text] [Related]
11. [The influence of microvessel density in the tumor on the prognosis in patients with stage I-II non-small cell lung cancer after surgical treatment].
Kolesnik AP; Shevchenko AI; Tumanskiĭ VA; Evseev AV; Shishkin MA
Vopr Onkol; 2013; 59(6):735-9. PubMed ID: 24624783
[TBL] [Abstract][Full Text] [Related]
12. Number of circulating endothelial progenitor cells and intratumoral microvessel density in non-small cell lung cancer patients: differences in angiogenic status between adenocarcinoma histologic subtypes.
Maeda R; Ishii G; Ito M; Hishida T; Yoshida J; Nishimura M; Haga H; Nagai K; Ochiai A
J Thorac Oncol; 2012 Mar; 7(3):503-11. PubMed ID: 22198428
[TBL] [Abstract][Full Text] [Related]
13. Tumor angiogenesis as a prognostic marker in operable non-small cell lung cancer.
Matsuyama K; Chiba Y; Sasaki M; Tanaka H; Muraoka R; Tanigawa N
Ann Thorac Surg; 1998 May; 65(5):1405-9. PubMed ID: 9594875
[TBL] [Abstract][Full Text] [Related]
14. Net platelet angiogenic activity (NPAA) correlates with progression and prognosis of non-small cell lung cancer.
Yao L; Dong H; Luo Y; Du J; Hu W
PLoS One; 2014; 9(4):e96206. PubMed ID: 24788022
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of tumoral angiogenesis in completely resected late stage lung carcinoma (stage IIIA-N2). Impact of adjuvant therapies in a subset of patients at high risk of recurrence.
Angeletti CA; Lucchi M; Fontanini G; Mussi A; Chella A; Ribechini A; Vignati S; Bevilacqua G
Cancer; 1996 Aug; 78(3):409-15. PubMed ID: 8697384
[TBL] [Abstract][Full Text] [Related]
16. Correlation of total VEGF mRNA and protein expression with histologic type, tumor angiogenesis, patient survival and timing of relapse in non-small-cell lung cancer.
Yuan A; Yu CJ; Chen WJ; Lin FY; Kuo SH; Luh KT; Yang PC
Int J Cancer; 2000 Nov; 89(6):475-83. PubMed ID: 11102890
[TBL] [Abstract][Full Text] [Related]
17. Inverse prognostic impact of angiogenic marker expression in tumor cells versus stromal cells in non small cell lung cancer.
Donnem T; Al-Saad S; Al-Shibli K; Delghandi MP; Persson M; Nilsen MN; Busund LT; Bremnes RM
Clin Cancer Res; 2007 Nov; 13(22 Pt 1):6649-57. PubMed ID: 18006765
[TBL] [Abstract][Full Text] [Related]
18. Glomeruloid microvascular proliferation is superior to intratumoral microvessel density as a prognostic marker in non-small cell lung cancer.
Tanaka F; Oyanagi H; Takenaka K; Ishikawa S; Yanagihara K; Miyahara R; Kawano Y; Li M; Otake Y; Wada H
Cancer Res; 2003 Oct; 63(20):6791-4. PubMed ID: 14583475
[TBL] [Abstract][Full Text] [Related]
19. Breast carcinoma vascularity: a comparison of manual microvessel count and Chalkley count.
Dhakal HP; Bassarova A; Naume B; Synnestvedt M; Borgen E; Kaaresen R; Schlichting E; Wiedswang G; Giercksky KE; Nesland JM
Histol Histopathol; 2009 Aug; 24(8):1049-59. PubMed ID: 19554512
[TBL] [Abstract][Full Text] [Related]
20. Angiogenesis in non-small cell lung cancer: the prognostic impact of neoangiogenesis and the cytokines VEGF and bFGF in tumours and blood.
Bremnes RM; Camps C; Sirera R
Lung Cancer; 2006 Feb; 51(2):143-58. PubMed ID: 16360975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
